{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T18:20:30Z","timestamp":1773858030171,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,7,20]],"date-time":"2004-07-20T00:00:00Z","timestamp":1090281600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1007\/s00401-004-0891-6","type":"journal-article","created":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T11:20:35Z","timestamp":1088680835000},"page":"295-301","source":"Crossref","is-referenced-by-count":45,"title":["Clusterin solubility and aggregation in Creutzfeldt-Jakob disease"],"prefix":"10.1007","volume":"108","author":[{"given":"M.","family":"Freixes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Puig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rodr\ufffdguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Torrej\ufffdn-Escribano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,7,20]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1046\/j.1471-4159.1996.67031324.x","volume":"67","author":"Boggs","year":"1996","unstructured":"Boggs LN, Fuson KS, Bae M, Churgay L, McClure D, Becker G, May PC (1996) Clusterin (ApoJ) protects against in vitro amyloid-? (1?40) neurotoxicity. J Neurochem 67:1324?1327","journal-title":"J Neurochem"},{"key":"CR2","unstructured":"Budka H, Head MW, Ironside JW, Gambetti P, Parchi P, Zeidler M, Tagliavini F (2003) Sporadic Creutzfeldt-Jakob disease. In: Dickson D (ed) Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropath Press, Basel, pp 287?297"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/0092-8674(93)90360-3","volume":"73","author":"Bueler","year":"1993","unstructured":"Bueler H, Aguzzi A, Sailier A, Greiner RA, Autenried P, Aguet M, Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73:1339?1347","journal-title":"Cell"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1016\/0197-4580(94)93095-3","volume":"15","author":"Bugiani","year":"1994","unstructured":"Bugiani O, Giaccone G, Frigerio L, Farlow MR, Ghetti B, Tagliavini F (1994) Apolipoprotein E and J in immunoreactivity in Gerstmann-Str\u00e4ussler-Scheinker disease. Neurobiol Aging 15:S156?S157","journal-title":"Neurobiol Aging"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1460-9568.1996.tb01244.x","volume":"8","author":"Chiesa","year":"1996","unstructured":"Chiesa R, Angeretti N, Lucca E, Salmona M, Tagliavini F, Bugiani O, Forloni G (1996) Clusterin (SGP-2) induction in rat astroglial cells exposed to prion protein fragment 106?126. Eur J Neurosci 8:589?597","journal-title":"Eur J Neurosci"},{"key":"CR6","first-page":"717","volume":"17","author":"Choi-Miura","year":"1996","unstructured":"Choi-Miura NH, Oda T (1996) Relationship between multifunctional protein clusterin and Alzheimer?s disease. Neurobiol Aging 17:717?722","journal-title":"Neurobiol Aging"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF00296787","volume":"83","author":"Choi-Miura","year":"1992","unstructured":"Choi-Miura NH, Ihara Y, Fukuchi K, Takeda M, Nakano Y, Tobe T, Tomita M (1992) SP-40,40 is a constituent of Alzheimer?s amyloid. Acta Neuropathol 83:260?264","journal-title":"Acta Neuropathol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","volume":"24","author":"Collinge","year":"2001","unstructured":"Collinge J (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24:519?550","journal-title":"Annu Rev Neurosci"},{"key":"CR9","unstructured":"DeArmond SJ, Kretzschmar HA, Prusiner SB (2003) Prion diseases. In: Graham DI, Lantos PL (eds) Greenfield?s neuropathology, vol 2, 7th edn. Arnold, London, pp 273?323"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"10843","DOI":"10.1073\/pnas.162228299","volume":"99","author":"DeMattos","year":"2002","unstructured":"DeMattos RB, O?dell MA, Parsadanian M, Taylor JW, Harmony JAK, Bales KR, Paul SM, Aronow BJ, Holtzman DM (2002) Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer?s disease. Proc Natl Acad Sci USA 99:10843?10848","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0306-4522(00)00045-2","volume":"97","author":"Ferrer","year":"2000","unstructured":"Ferrer I, Puig B, Blanco R, Mart\u00ed E (2000) Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeld-Jakob disease. Neuroscience 97:715?726","journal-title":"Neuroscience"},{"key":"CR12","unstructured":"Gambetti P, Parchi P, Chen SG, Cortelli P, Lugaresi E, Montagna P (2003) Fatal insomnia: familial and sporadic. In: Dickson D (ed )Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropath Press, Basel, pp 326?332"},{"key":"CR13","unstructured":"Ghetti B, Bugiani O, Tagliavini F, Piccardo P (2003) Gerstmann-Str\u00e4ussler-Scheinker disease. In: Dickson D (ed) Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropath Press, Basel, pp 318?325"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1042\/bj2930027","volume":"293","author":"Ghiso","year":"1993","unstructured":"Ghiso J, Matsubaara E, Koudinov A, Choi-Miura H, Tomita M, Wisniewski T, Frangione B (1993) The cerebrospinal fluid soluble form of Alzheimer?s amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem J 293:27?30","journal-title":"Biochem J"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/85487","volume":"7","author":"Han","year":"2001","unstructured":"Han BH, DeMattos RB, Dugan LL, Kim-Han RP, Brendza JD, Fryer M, Kierson M, Cirrito J, Quick K, Harmony JAK, Aronow BJ, Holtzman DM (2001) Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia. Nat Med 7:338?343","journal-title":"Nat Med"},{"key":"CR16","doi-asserted-by":"crossref","unstructured":"Ironside JW, Head MW, Will RG (2003) Variant Creutzfeldt-Jakob disease. In: Dickson D (ed) Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropath Press, Basel, pp 310?317","DOI":"10.1023\/B:VERC.0000014111.12833.df"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1357-2725(01)00155-8","volume":"34","author":"Jones","year":"2002","unstructured":"Jones SE, Jomary C (2002) Clusterin. Int J Biochem Cell Biol 34:427?431","journal-title":"Int J Biochem Cell Biol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1006\/exnr.1998.6892","volume":"154","author":"Lidstr\u00f6m","year":"1998","unstructured":"Lidstr\u00f6m AM, Bogdanovic N, Hesse C, Volkman I, Davidsson P, Blennow K (1998) Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer?s disease. Exp Neurol 154:511?521","journal-title":"Exp Neurol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1074\/jbc.270.13.7563","volume":"270","author":"Matsubara","year":"1995","unstructured":"Matsubara E, Frangione B, Ghiso J (1995) Characterization of apolipoprotein J-Alzheimer?s A beta interactions. J Biol Chem 270:7563?7567","journal-title":"J Biol Chem"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0006-8993(92)90071-G","volume":"579","author":"McGeer","year":"1992","unstructured":"McGeer PL, Kawamata T, Walker DG (1992) Distribution of clusterin in Alzheimer brain tissue. Brain Res 579:337?341","journal-title":"Brain Res"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1006\/bbrc.1999.0781","volume":"259","author":"McHattie","year":"1999","unstructured":"McHattie S, Edington N (1999) Clusterin prevents aggregation of neuropeptide 106?126 in vitro. Biochem Biophys Res Commun 259:336?340","journal-title":"Biochem Biophys Res Commun"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/jcpa.1999.0313","volume":"121","author":"McHattie","year":"1999","unstructured":"McHattie S, Wells GAH, Bee J, Edington N (1999) Clusterin in bovine spongiform encephalopathy (BSE). J Comp Pathol 121:159?171","journal-title":"J Comp Pathol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1172\/JCI9037","volume":"106","author":"McLaughlin","year":"2000","unstructured":"McLaughlin L, Zhu G, Mistry M, Ley-Ebert C, Stuart WD, Florio CJ, Groen PA, Witt SA, Kimball TR, Witte DP, Harmony JA, Aronow BJ (2000) Apolipoprotein J\/clusterin limits the severity of murine autoimmune myocarditis. J Clin Invest 106:1105?1113","journal-title":"J Clin Invest"},{"key":"CR24","unstructured":"McLean CA (2003) Kuru. In: Dickson D (ed) Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropath Press, Basel, pp 333?334"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/bj3280045","volume":"328","author":"Michel","year":"1997","unstructured":"Michel D, Chatealin G, North S, Brun G (1997) Stress-induced transcription of the clusterin\/apoJ gene. Biochem J 328:45?50","journal-title":"Biochem J"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","volume":"46","author":"Parchi","year":"1999","unstructured":"Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberg N, Julien J, Vital C, Guetti B, Gambetti P, Kretzschmar H (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224?233","journal-title":"Ann Neurol"},{"key":"CR27","unstructured":"Parchi P, Capellari S, Chen SG, Gambetti P (2003) Familial Creutzfeldt-Jakob disease. In: Dickson D (ed) Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropath Press, Basel, pp 298?306"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1523\/JNEUROSCI.13-04-01676.1993","volume":"13","author":"Pike","year":"1993","unstructured":"Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW (1993) Neurodegeneration induced by amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 13:1676?1687","journal-title":"J Neurosci"},{"key":"CR29","unstructured":"Prusiner SB (1997) The prion diseases of humans and animals. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL (eds) The molecular and genetic basis of neurological diseases, 2nd edn. Butterworth-Heinemann, Boston, pp 165?186"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"10608","DOI":"10.1073\/pnas.90.22.10608","volume":"90","author":"Prusiner","year":"1993","unstructured":"Prusiner SB, Groth D, Serban A, Koehler R, Foster D, Torchia M, Burton D, Yang SL, DeArmond SJ (1993) Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci USA 90:10608?10612","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR31","unstructured":"Rickets MN, Pergami P (2003) Iatrogenic prion diseases. In: Dickson D (ed) Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropath Press, Basel, pp 307?309"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/1357-2725(95)00027-M","volume":"27","author":"Rosenberg","year":"1995","unstructured":"Rosenberg ME, Silkensen J (1995) Clusterin: physiological and pathological considerations. Int Biochem Cell Biol 27:63?645","journal-title":"Int Biochem Cell Biol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s004010100456","volume":"103","author":"Sasaki","year":"2002","unstructured":"Sasaki K, Doh-ura K, Ironside JW, Iwaki T (2002) Increased clusterin (apolipoprotein J) expression in human and mouse brains infected with transmissible spongiform encephalopathies. Acta Neuropathol 103:199?208","journal-title":"Acta Neuropathol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00401-002-0532-x","volume":"104","author":"Sasaki","year":"2002","unstructured":"Sasaki K, Doh-ura K, Wakisawa Y, Iwaki T (2002) Clusterin\/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with ?-synucleinopathies. Acta Neuropathol 104:225?230","journal-title":"Acta Neuropathol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1046\/j.1523-1755.1998.00902.x","volume":"53","author":"Schwochan","year":"1998","unstructured":"Schwochan GB, Nath KA, Rosenberg ME, (1998) Clusterin protects against oxidative stress in vitro through aggregative and non-aggregative properties. Kidney Int 53:1647?1653","journal-title":"Kidney Int"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0968-0004(99)01534-0","volume":"25","author":"Wilson","year":"2000","unstructured":"Wilson MR, Easterbrook-Smith SB (2000) Clusterin is a secreted mammalian chaperone. Trends Biochem Sci 25:95?98","journal-title":"Trends Biochem Sci"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1073\/pnas.97.11.5907","volume":"97","author":"Yang","year":"2000","unstructured":"Yang ChR, Leskov K, Elberlein H, Criswell T, Pink JJ, Kinsella TJ, Boothman DA (2000) Nuclear clusterin\/XIP8, and x-ray-induced Ku70-binding protein that signals cell death. Proc Natl Acad Sci USA 97:5907?5912","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/0024-3205(96)00310-4","volume":"59","author":"Zlokovic","year":"1996","unstructured":"Zlokovic BV (1996) Cerebrovascular transport of Alzheimer?s amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood brain barrier. Life Sci 59:1483?1497","journal-title":"Life Sci"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-004-0891-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-004-0891-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-004-0891-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:22:56Z","timestamp":1559064176000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-004-0891-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,20]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["891"],"URL":"https:\/\/doi.org\/10.1007\/s00401-004-0891-6","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,20]]}}}